Cargando…
PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428946/ http://dx.doi.org/10.1097/01.HS9.0000976180.72680.25 |
| _version_ | 1785090592885178368 |
|---|---|
| author | Segura, Cecilia Carmen Carpio Namuduri, Manjusha Liu, Dishan Sophos, Nickolas A. Zhu, Min Sabir, Ayesha Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Garcia-Sancho, Alejandro Martin |
| author_facet | Segura, Cecilia Carmen Carpio Namuduri, Manjusha Liu, Dishan Sophos, Nickolas A. Zhu, Min Sabir, Ayesha Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Garcia-Sancho, Alejandro Martin |
| author_sort | Segura, Cecilia Carmen Carpio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428946 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289462023-08-17 PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA Segura, Cecilia Carmen Carpio Namuduri, Manjusha Liu, Dishan Sophos, Nickolas A. Zhu, Min Sabir, Ayesha Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Garcia-Sancho, Alejandro Martin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428946/ http://dx.doi.org/10.1097/01.HS9.0000976180.72680.25 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Segura, Cecilia Carmen Carpio Namuduri, Manjusha Liu, Dishan Sophos, Nickolas A. Zhu, Min Sabir, Ayesha Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Garcia-Sancho, Alejandro Martin PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title | PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title_full | PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title_fullStr | PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title_full_unstemmed | PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title_short | PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA |
| title_sort | pb2366: trial in progress: phase 1 trial evaluating the safety and tolerability of odronextamab in combination with cemiplimab in relapsed/refractory aggressive b-cell non-hodgkin lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428946/ http://dx.doi.org/10.1097/01.HS9.0000976180.72680.25 |
| work_keys_str_mv | AT seguraceciliacarmencarpio pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT namudurimanjusha pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT liudishan pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT sophosnickolasa pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT zhumin pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT sabirayesha pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT brouwervisserjurriaan pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT chaudhryaafia pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT mohamedhesham pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma AT garciasanchoalejandromartin pb2366trialinprogressphase1trialevaluatingthesafetyandtolerabilityofodronextamabincombinationwithcemiplimabinrelapsedrefractoryaggressivebcellnonhodgkinlymphoma |